1,719 results on '"BUGELSKI, PETER J."'
Search Results
2. Transgenic Animals
3. Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis
4. Development of a murine model of lymph node metastases suitable for immunotoxicity studies
5. Transgenic Animals
6. CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools
7. Binding of Soluble CD4 Proteins to Human Immunodeficiency Virus Type 1 and Infected Cells Induces Release of Envelope Glycoprotein gp120
8. Pharmacodynamics of Recombinant Human Erythropoietin in Murine Bone Marrow
9. Genetic aspects of immune-mediated adverse drug effects
10. A Strategy for Primary High Throughput Cytotoxicity Screening in Pharmaceutical Toxicology
11. Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
12. Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets
13. Alternative Animal Models for Immunomodulation and Immunotoxicity
14. Application of Flow Cytometry in Drug Development
15. Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
16. Monoclonal antibody-induced cytokine-release syndrome
17. 106 Strategy for a robust preclinical human assay to assess potential for cytokine release syndrome with therapeutic antibodies
18. Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species
19. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
20. Lakota powwow songs and dances: observations from Rosebud fair
21. Soluble recombinant CD4 — A potential therapeutic agent for HIV infection
22. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys
23. IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES
24. Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice
25. Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees
26. Selective Inhibition of Phospholipases by Atiprimod, a Macrophage Targeting Antiarthritic Compound
27. Atiprimod (SKandF 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppresive in candida-infected mice
28. Recruitment of exogenous macrophages into metastases at different stages of tumor growth
29. Toxicity of Troglitazone in Cultured Rat Hepatocytes
30. Immunomodulatory Biopharmaceuticals and Risk of Neoplasia
31. Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice
32. Differential Effects of Long-lived Erythropoietin Receptor Agonists in Rats
33. A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes
34. Pharmacodynamics of CNTO 530 and Darbepoetin-α in Human TNF-α Transgenic Mice, a Murine Model of Anemia of Chronic Disease
35. Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia
36. Activity of CNTO 530 in a murine model of sickle cell anemia
37. Development of a murine model of tumor promotion and progression for immunotoxicity testing
38. Immunomodulatory Biopharmaceuticals and Risk of Neoplasia
39. Effects of CNTO 530, an erythropoietin mimetic‐IgG4 fusion protein, on embryofetal development in rats and rabbits
40. Long-term activation of TLR3 by Poly(I:C) induces inflammation and impairs lung function in mice
41. Sequential univariate gating approach to study the effects of erythropoietin in murine bone marrow
42. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-α transgenic mice
43. Interference with Tissue Factor Prolongs Intrahepatic Islet Allograft Survival in a Nonhuman Primate Marginal Mass Model
44. Pharmacodynamics of Recombinant Human Erythropoietin in Murine Bone Marrow
45. T-Dependent Antigen Response (TDAR) Tests: Meta-Analysis of Results Generated Across Multiple Laboratories
46. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow
47. Role of Fas / FasL in Regulation of Basophillic Erythroblast Homeostasis.
48. ANALYSIS OF THE EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPO) ON MURINE BONE MARROW POPULATIONS USING MIXTURE MODELING TECHNIQUES
49. Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Cancer in Patients
50. Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.